Gene Editing Pioneer Musunuru Cautions on Baby KJ's Treatment
Dr. Kiran Musunuru, a leading figure in gene editing, addressed the American Society of Gene and Cell Therapy, emphasizing the limitations of a recent gene editing treatment for Baby KJ, an infant with a rare urea cycle disorder. While the treatment was initially celebrated, Musunuru clarified that it was not a cure but a personalized therapy with limited broader applicability. He stressed the need for rigorous clinical trials and ethical responsibility in gene editing, highlighting ongoing efforts to develop therapies for phenylketonuria and urea cycle disorders. 
